...
首页> 外文期刊>Methods and findings in experimental and clinical pharmacology >Pharmacological activity and structural analysis of a benzamide (TKS159) and its optical isomers in an in vitro study and in an in vivo study in mice.
【24h】

Pharmacological activity and structural analysis of a benzamide (TKS159) and its optical isomers in an in vitro study and in an in vivo study in mice.

机译:在小鼠的体内研究和体内研究中,苯甲酰胺(TKS159)及其旋光异构体的药理活性和结构分析。

获取原文
获取原文并翻译 | 示例

摘要

We previously conducted an in vitro study of 4-amino-5-chloro-2-methoxy-N-(1-ethyl-2-hydroxymethyl-4-pyrrolidinyl)benza mide (2S,4S)-(1, TKS159) and its three optical isomers (2S,4R)-(2), (2R,4S)-(3) and (2R,4R)-(4) with respect to their binding ability to the 5-HT(4) receptors, as well as an in vivo study on their gastric emptying-accelerating ability in rats. Consequently, we reported that steric configuration at positions 2 and 4 of the pyrrolidine ring is important in determining their pharmacological activity. The optical isomer (2R,4S)-(3) exhibited the most potent binding ability. However, the compound (2S,4S)-(1, TKS159) exhibited the most potent gastric emptying-accelerating ability in rats. A difference was thus found between binding ability and gastric emptying-accelerating ability in rats. Therefore, we conducted an in vitro study of TKS159 (1) and its three optical isomers to examine their agonistic activity on the 5-HT(4) receptors, as well as an in vivo study in mice to examine their gastric emptying-accelerating ability. Consequently, a tendency for correlation was found between the activity and the ability. TKS159 (1) exhibited the most potent pharmacological activity, well reflecting the results from the previous in vivo study in rats. Furthermore, the present in vitro and in vivo studies reverified the importance of steric configuration at positions 2 and 4 of the pyrrolidine ring. In addition, we also made an X-ray crystallographic analysis of the optical isomer (2R,4S)-(3), which has the S-configuration at position 4 similar to TKS159 (1), and discussed molecular structures in conjunction with the previously reported results from the X-ray crystallographic analysis of TKS159 (1). (c) 2007 Prous Science. All rights reserved.
机译:我们之前进行了4-氨基-5-氯-2-甲氧基-N-(1-乙基-2-羟甲基-4-吡咯烷基)苯甲醛(2S,4S)-(1,TKS159)的体外研究三个光学异构体(2S,4R)-(2),(2R,4S)-(3)和(2R,4R)-(4)关于它们与5-HT(4)受体的结合能力作为大鼠胃排空促进能力的体内研究。因此,我们报道了在吡咯烷环的2和4位的空间构型对于确定其药理活性很重要。旋光异构体(2R,4S)-(3)显示出最有效的结合能力。然而,化合物(2S,4S)-(1,TKS159)在大鼠中表现出最有效的胃排空促进能力。因此发现大鼠的结合能力和胃排空促进能力之间存在差异。因此,我们进行了TKS159(1)及其三个旋光异构体的体外研究,以研究其对5-HT(4)受体的激动活性,以及​​在小鼠中进行的体内研究,以研究其加速胃排空的能力。因此,在活动和能力之间发现了相关的趋势。 TKS159(1)表现出最有效的药理活性,很好地反映了先前在大鼠体内研究的结果。此外,目前的体外和体内研究证实了吡咯烷环的2和4位的空间构型的重要性。此外,我们还对光学异构体(2R,4S)-(3)进行了X射线晶体学分析,该异构体在4位具有类似于TKS159(1)的S-构型,并与该异构体一起讨论了分子结构先前报道的TKS159 X射线晶体学分析结果(1)。 (c)2007 Prous科学。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号